Correction: Conversion therapy with TACE, TKIs, and ICIs for unresectable BCLC stage B and C hepatocellular carcinoma - Wang, Zhuoran; Zhang, Cunzhen; Yin, Jianhua; Li, Nan (Frontiers in Immunology, 2025)